Balyasny Asset Management’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
Other funds holding INSP
DM
VPM
VCM
Balyasny Asset Management's INSP Position: Q1 2026 in Review
Balyasny Asset Management reduced its Inspire Medical Systems (INSP) stake by 19% in Q1 2026, selling an estimated $2.48M and leaving 151,856 shares worth $7.83M. The position accounts for 0.01% of the portfolio, ranked #1146.
Balyasny Asset Management first reported a position in INSP in Q1 2019 and has held it in 17 quarters since. The position peaked at $45.6M in Q3 2025. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.
- Balyasny Asset Management held 151,856 shares of Inspire Medical Systems worth $7.83M as of Q1 2026.
- Balyasny Asset Management sold 35,370 Inspire Medical Systems shares in Q1 2026, an estimated $2.48M.
- Inspire Medical Systems made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1146 holding.
- Balyasny Asset Management first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 17 quarters since.
- Balyasny Asset Management's Inspire Medical Systems position peaked at $45.6M in Q3 2025.
- 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.